Tradestie Institutional Equity Comparison Engine
NTLA vs PHVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PHVS Overall Edge
PHVS Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pharvaris N.V. Ordinary Shares (PHVS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus PHVS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against PHVS sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NTLA N/M vs PHVS N/M Fwd P/E
Growth & Margin Winner
PHVS
Op Margin -826.0% vs 0.0% ยท YoY -48.0% vs +0.0%
Momentum & Technical Winner
PHVS
1Y +15.3% vs +34.4% ยท 52W Pos 20% vs 48%
Options & Structure Winner
PHVS
BREAKDOWN (78th %ile IV) vs CONSOLIDATION (7th %ile IV)
NTLA
NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap
$1.5B
1M Return
-12.43%
1Y Return
+15.34%
Forward P/E
N/M
Unified AI Score
49.9 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 59.0
Mom 60.0
PHVS
NASDAQ
Pharvaris N.V. Ordinary Shares
Pharmaceutical Preparations
$32.61
-2.25% 1D
Market Cap
$2.4B
1M Return
+17.56%
1Y Return
+34.42%
Forward P/E
N/M
Unified AI Score
44.1 / 100
HOLD
Tech 37.0
Fund 47.0
Flow 58.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NTLA +15.34%
PHVS +34.42%
Spread: +19.08 pp (PHVS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NTLA TTM Op. Margin: -826.0%
PHVS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NTLA vs PHVS. Trailing 12-month operating profitability (NTLA -826.0% vs PHVS 0.0%) and valuation multiples (NTLA N/M vs PHVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NTLA | PHVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $2.4B | Larger Scale | PHVS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -48.0% | +0.0% | Higher Growth | PHVS |
| Operating Margin (TTM) Profitability | -826.0% | 0.0% | Higher Margin | PHVS |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.6% | -70.5% | Higher ROE | NTLA |
| 52-Week Range Position Momentum | 20% ($8โ$18) | 48% ($23โ$43) | Stronger Trend | PHVS |
| Beta / 30D Volatility Risk Regime | 2.30ฮฒ ยท 87% Vol | 0.67ฮฒ ยท 38% Vol | Lower Realized Risk | PHVS |
| Unified Institutional Score Composite Signal | 49.9 / 100 (HOLD) | 44.1 / 100 (HOLD) | Higher Composite | NTLA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NTLA vs PHVS Buy Guide
NTLA
BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
78th %ile
IV Regime
Elevated (60thโ80th %ile)
PHVS
CONSOLIDATION
105d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NTLA nor PHVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.